Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies.

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies. The pattern of inattention, ...

In February, the Louisiana Department of Health launched a new era of person-centered care for mothers affected by substance use disorder with the announcement of 11 inaugural Project M.O.M. (Maternal ...

Ryan Paige has called Biddeford home his entire life. He grew up in the city, attended its schools and spent time with ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

Substance use disorder makes it hard to stop using substances even when they're harmful. Using the term "substance use disorder" helps separate the person from the treatable illness. Substance use ...

GLP-1 receptor agonist-related agonism may prevent addiction phenotypes across all major drug classes according to authors of a recent study.

Addiction is an umbrella term that reflects qualities of substance use disorder, characterized by an inability to stop using a substance despite harmful consequences. However, addiction is not a ...

Mainspring Recovery, opens new tab, a Virginia-based addiction treatment provider, says its clinical leadership is closely monitoring the evolving overdose landscape and will continue sharing insights ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Substance use and substance use disorder differ by the frequency of use and the effect on a person’s life. Substance use disorder is a mental health condition. Substance use refers to using both legal ...